Kangstem Biotech

Stem cell therapeutics

217730 · KOSDAQ · South Korea

Public Market Listing

217730KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for Kangstem Biotech are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Furestem-CDNo recent activity
Phase 1/2
Allogeneic MSC therapyCell therapy
Inflammatory Bowel Disease
Crohn's Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Quarterly & interim (1)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2026-Q3————report ↗